Lumida
/UTHR
⌘K
United Therapeutics Corp

United Therapeutics Corp

UTHR
$497.11USD-1.34%-6.75 today

MARKET CAP

21.3B

P/E (TTM)

18.0x

FWD P/E

18.7x

DAY RANGE

$496 – $509

52W RANGE

$395
$609

AI Summary

Stalk
StalkMedium

UTHR remains in a corrective pullback below declining EMAs into oversold extremes within its broader uptrend. Mean-reversion eligibility grants a medium-term bullish bias, but short-term timing disfavors entry until price demonstrates support acceptance near the 480–490 zone. Execution is deferred pending clear pullback absorption.

  • Pipeline catalysts: Rilinopag & nebulized Tyveso could unlock multi-$B revenues pending 2027 approvals
  • Q2 EPS grew to $7.27 from $6.41 YoY despite flat $783M revenues
  • Q2 revenue was flat at $783M YoY, showing limited top-line growth
Full analysis →

Buying

11

institutions

Selling

8

institutions

New Positions

2

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

SELL5.29 M2.87 B+-105.12 K-10.4%0.04%
JH

Janus Henderson Group Plc

Q1 2026

BUY1.73 M1.03 B+937.76 K+165.1%0.25%
RT

Renaissance Technologies LLC

Q2 2026

SELL1.71 M925.85 M+-78.28 K-12.6%1.28%
CA

Citadel Advisors LLC

Q2 2026

BUY747.99 K405.28 M+50.15 K-2.1%0.05%
AC

Aqr Capital Management LLC

Q2 2026

SELL546.00 K294.64 M+-280.22 K-39.4%0.10%
MM

Millennium Management LLC

Q2 2026

BUY485.07 K262.83 M+180.30 K+45.4%0.10%
EP

Eversept Partners, LP

Q2 2026

BUY287.67 K155.87 M+23.40 K-0.5%8.09%
JC

Jpmorgan Chase & Co

Q2 2026

SELL275.36 K151.01 M+-16.26 K-12.0%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY201.16 K108.99 M+30.46 K+7.7%0.12%
MG

Man Group Plc

Q2 2026

BUY134.89 K73.09 M+57.40 K+59.0%0.12%
BA

Bridgewater Associates, LP

Q2 2026

BUY111.33 K60.32 M+157.00-8.5%0.25%
CP

California Public Employees Retirement System

Q2 2026

BUY88.70 K48.06 M+407.00-8.2%0.03%
FA

Fisher Asset Management, LLC

Q2 2026

SELL33.84 K18.33 M+-568.00-10.1%0.01%
WP

Woodline Partners LP

Q2 2026

BUY23.07 K12.50 M+16.12 K+203.2%0.04%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL7.81 K4.23 M+-28.82 K-80.5%0.01%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW4.17 K2.26 M+4.17 K+0.0%0.02%
GM

Grantham, Mayo, Van Otterloo & Co. LLC

Q2 2026

SELL3.28 K1.78 M+-175.00-13.3%0.00%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

BUYNEW2.10 K1.14 M+2.10 K+0.0%0.26%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL1.51 K816.00 K+-56.00-11.9%0.00%